home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

2.330 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Reasons to Sell EVH and 1 Stock to Buy Instead

March 07, 2025

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have...

Via StockStory

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.

Via StockStory

Evolent Health (EVH) Q4 2024 Earnings Call Transcript ↗

February 21, 2025

EVH earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Evolent Health (NYSE:EVH) Misses Q4 Sales Targets

February 20, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue guidance...

Via StockStory

Topics Economy

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) ↗

February 12, 2025

Via Benzinga

What Analysts Are Saying About Evolent Health Stock ↗

January 14, 2025

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Evolent Health ↗

November 08, 2024

Via Benzinga

Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For

February 19, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect.

Via StockStory

Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates

January 31, 2025

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was...

Via StockStory

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining ↗

November 22, 2024

Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.

Via Benzinga

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts ↗

October 08, 2024

Via Benzinga

What 4 Analyst Ratings Have To Say About Evolent Health ↗

August 19, 2024

Via Benzinga

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗

November 17, 2024

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Via Benzinga

S&P 500 Tops 6,000; Sezzle Shares Spike Higher ↗

November 08, 2024

Via Benzinga

Topics Stocks

Dow Tops 44,000; US Consumer Sentiment Increases In November ↗

November 08, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 08, 2024

Via Benzinga

US Stocks Mixed; Fluor Earnings Miss Views ↗

November 08, 2024

Via Benzinga

Topics Earnings

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2024

Via Benzinga

Evolent Health (EVH) Q3 2024 Earnings Call Transcript ↗

November 08, 2024

EVH earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Humana and Evolent Expand Partnership to Enhance Oncology Care

November 07, 2024

From Evolent Health, Inc.

Via Business Wire

Why Is Elevance Health Stock Trading Lower On Thursday? ↗

October 17, 2024

Evolent Health stock reacted negatively amid Elevance Health's mixed results and Medicaid utilization pressures.

Via Benzinga

AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio? ↗

September 08, 2024

The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.

Via Benzinga

Topics Artificial Intelligence

Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio? ↗

August 25, 2024

Via Benzinga

Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms ↗

August 23, 2024

Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.

Via Benzinga

Four Stocks To Watch This Week - Monday, Aug. 19 ↗

August 19, 2024

Thursday's market surge transformed bearish trends into bullish breakouts, with many stocks jumping above their Key Levels. Here are 4 stocks to keep on your radar this week.

Via Talk Markets

Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday ↗

August 09, 2024

Via Benzinga

Evolent Health (EVH) Q2 2024 Earnings Call Transcript ↗

August 09, 2024

EVH earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com